At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 5, 2026 at 19:00 ET
Nuvalent's Chief Scientific Officer, Henry E. Pelish, sold 24,993 shares in open-market transactions over two days, realizing approximately $2.44 million in proceeds. The sales were accompanied by the exercise of derivative securities for 16,912 shares, with minimal cash outlay. The total open-market sell value represents a small fraction of Nuvalent's $7.7B market cap.
- Chief Scientific Officer Henry E. Pelish sold 24,993 shares in open-market transactions on March 12 and 13, 2026, for total proceeds of $2,444,145.87.
- Pelish also exercised derivative securities for 16,912 shares, with a nominal cost of $160,072.08 and one tranche at $0 (non-cash).
- Total open-market sale value: ~$2.44M, representing 0.03% of Nuvalent’s $7.7B market cap.
- All transactions were reported on Form 4 and appear to be part of a pre-arranged trading plan or portfolio diversification.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access